Thursday, June 20, 2013
Publication and contact
A microchip platform to
model heart failure
A microchip platform could
be used to model failing myocardium and identify molecules to prevent
myocardial infarction (MI) or hypertension. The device consists of neonatal
rat ventricular myocytes seeded on a fibronectin-patterned flexible silicone
membrane that is cyclically stretched to induce disease phenotypes.
Myocardium that underwent cyclic stretching showed pathologic changes to
myocyte shape, sarcomere alignment and gene expression, and it had decreased
contractile functions compared with unstretched myocardium. Next steps
include using the microchip platform to test compounds currently used to
treat heart failure, comparing results to those reported in animal models and
the clinic, and adapting the microchip platform to include human stem cell-derived
Published online June 20, 2013
Patented; licensed to TissueNetix Inc.
McCain, M.L. et al.
Proc. Natl. Acad. Sci. USA; published online
May 28, 2013;
Contact: Kevin Kit Parker, Harvard University,
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]